keyword
https://read.qxmd.com/read/38629377/exploring-the-therapeutic-potential-of-anti-vegf-drugs-for-the-management-of-diabetic-retinopathy-an-overview
#21
JOURNAL ARTICLE
Aman Khandelwal, K Gowthamarajan, Jayabalan Nirmal, S Ponnusankar
The discovery of antivascular endothelial growth factor medications has resulted in a substantial change in diabetic retinopathy treatment. The most common cause of diabetic retinopathy blindness is Diabetic Macular Edema. The pathophysiology of Diabetic Macular Edema is thought to include the well-known pro-angiogenic and pro-permeability factor vascular endothelial growth factor. Over the past decade, drugs that impede the functions of vascular endothelial growth factors have established themselves as a standard-of-care treatment for a range of ocular ailments and improved patients' clinical results with diabetic retinopathy and Diabetic Macular Edema, and their frequency has grown exponentially with the introduction of these agents Pegaptanib, Ranibizumab, and Aflibercept which are approved for ophthalmic indications, while Bevacizumab is used off-label...
April 16, 2024: Current Diabetes Reviews
https://read.qxmd.com/read/38628648/traditional-chinese-medicine-in-osteoporosis-from-pathogenesis-to-potential-activity
#22
REVIEW
Gang Cao, ShaoQi Hu, Yan Ning, Xinyue Dou, Chuan Ding, Lu Wang, Zeping Wang, Xianan Sang, Qiao Yang, Jiangnan Shi, Min Hao, Xin Han
Osteoporosis characterized by decreased bone density and mass, is a systemic bone disease with the destruction of microstructure and increase in fragility. Osteoporosis is attributed to multiple causes, including aging, inflammation, diabetes mellitus, and other factors induced by the adverse effects of medications. Without treatment, osteoporosis will further progress and bring great trouble to human life. Due to the various causes, the treatment of osteoporosis is mainly aimed at improving bone metabolism, inhibiting bone resorption, and promoting bone formation...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38628546/a-double-network-porous-hydrogel-based-on-high-internal-phase-emulsions-as-a-vehicle-for-potassium-sucrose-octasulfate-delivery-accelerates-diabetic-wound-healing
#23
JOURNAL ARTICLE
Zhiwei Wang, Lingshun Sun, Weixing Wang, Zheng Wang, Ge Shi, Honglian Dai, Aixi Yu
Diabetic wounds are a difficult medical challenge. Excessive secretion of matrix metalloproteinase-9 (MMP-9) in diabetic wounds further degrades the extracellular matrix and growth factors and causes severe vascular damage, which seriously hinders diabetic wound healing. To solve these issues, a double-network porous hydrogel composed of poly (methyl methacrylate-co-acrylamide) (p(MMA-co-AM)) and polyvinyl alcohol (PVA) was constructed by the high internal phase emulsion (HIPE) technique for the delivery of potassium sucrose octasulfate (PSO), a drug that can inhibit MMPs, increase angiogenesis and improve microcirculation...
2024: Regenerative Biomaterials
https://read.qxmd.com/read/38628296/impact-of-the-number-of-modifiable-risk-factors-on-clinical-outcomes-after-percutaneous-coronary-intervention-an-analysis-from-the-e-ultimaster-registry
#24
JOURNAL ARTICLE
Ofer Kobo, Yaniv Levi, Rami Abu-Fanne, Clemens Von Birgelen, Antoine Guédès, Adel Aminian, Peep Laanmets, Willem Dewilde, Adam Witkowski, Jacques Monsegu, Andres Romo Iniguez, Majdi Halabi, Mamas A Mamas, Ariel Roguin
AIMS: A substantial proportion of the patients undergoing percutaneous coronary intervention (PCI) have none of the of standard modifiable cardiovascular risk factors (SMuRFs): hypertension, diabetes, hypercholesterolaemia and smoking. The aim of this analysis was to compare clinical outcomes after PCI according to the number of SMuRFs. METHODS: Patients with an indication for a PCI were stratified based upon the number of SMuRFs: 0, 1, 2 or 3-4. The primary outcome was target lesion failure (TLF), a composite of cardiac death, target vessel-related myocardial infarction or clinically driven target lesion revascularization at 1-year...
April 2024: IJC Heart & Vasculature
https://read.qxmd.com/read/38627767/exosomes-biogenesis-was-increased-in-metformin-treated-human-ovary-cancer-cells-possibly-to-mediate-resistance
#25
JOURNAL ARTICLE
Reza Abbasi, Vahid Nejati, Jafar Rezaie
BACKGROUND: Exosomes derived from tumor cells contribute to the pathogenesis of cancers. Metformin, the most usually used drug for type 2 diabetes, has been frequently investigated for anticancer effects. Here, we examined whether metformin affects exosomes signaling in human ovary cancer cells in vitro. METHODS: Human ovary cancer cells, including A2780 and Skov3 cells, were treated with metformin for either 24-48 h. Cell viability and caspase-3 activity were determined by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) and colorimetric assays respectively...
April 16, 2024: Cancer Cell International
https://read.qxmd.com/read/38627248/comparison-of-fungemia-caused-by-candida-and-non-candida-rare-yeasts-a-retrospective-study-from-a-tertiary-care-hospital
#26
JOURNAL ARTICLE
Yasemin Oz, Mustafa Yılmaz, Tuba Bulduk, Mehmet Basayigit, Eren Gunduz, Selma Metintas
Although Candida species are the most common cause of fungemia, non-Candida rare yeasts (NCY) have been increasingly reported worldwide. Although the importance of these yeast infections is recognized, current epidemiological information about these pathogens is limited and they have variable antifungal susceptibility profiles. In this study, we aimed to evaluate the clinical characteristics for fungemia caused by NCY by comparing with candidemia. The episodes of NCY fungemia between January 2011 and August 2023 were retrospectively evaluated in terms of clinical characteristics, predisposing factor and outcome...
April 16, 2024: Medical Mycology
https://read.qxmd.com/read/38626913/therapy-combining-glucagon-like-peptide-1-receptor-agonist-with-sodium-glucose-cotransporter-2-inhibitor-suppresses-atherosclerosis-in-diabetic-apoe-deficient-mice
#27
JOURNAL ARTICLE
Masahiro Takubo, Kentaro Watanabe, Hitoki Saito, Genta Kohno, Hisamitsu Ishihara
Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) have beneficial effects on cardiovascular disease in addition to their glucose-lowering effects. We directly compared the effects of these drugs when used individually or in combination on cardiovascular atherosclerotic lesion development using diabetic ApoE-deficient hyperlipidemic mice. Methods We treated ApoE-deficient mice with streptozotocin and nicotinamide, generating a type 2 diabetes model...
April 16, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38626909/glucagon-like-peptide-1-based-therapies-a-new-horizon-in-obesity-management
#28
JOURNAL ARTICLE
Jang Won Son, Soo Lim
Obesity is a significant risk factor for health issues like type 2 diabetes and cardiovascular disease. It often proves resistant to traditional lifestyle interventions, prompting a need for more precise therapeutic strategies. This has led to a focus on signaling pathways and neuroendocrine mechanisms to develop targeted obesity treatments. Recent developments in obesity management have been revolutionized by introducing novel glucagon-like peptide-1 (GLP-1) based drugs, such as semaglutide and tirzepatide...
April 16, 2024: Endocrinology and Metabolism
https://read.qxmd.com/read/38626310/comprehensive-safety-profile-of-dipeptidyl-peptidase-4-inhibitors-a-post-marketing-study-based-on-faers-database-using-signal-detection-algorithms
#29
JOURNAL ARTICLE
Dipika Bansal, Beema T Yoosuf, Muhammed Favas Kt, Pinaki Dutta
BACKGROUND: Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) have acquired a foothold in managing type 2 diabetes mellitus, but few concerns have arisen regarding their overall safety profile. The aim of this study is to assess the potential risk of DPP-4 inhibitors by analyzing data from the FDA Adverse Event Reporting System (FAERS) database. RESEARCH DESIGN AND METHODS: This is a retrospective study which explored the FAERS database till March 2023 for the collection of safety reports...
April 16, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38626012/predictors-for-liver-fibrosis-in-non-alcoholic-patients-with-psoriatic-diseases-a-multicenter-cross-sectional-study
#30
JOURNAL ARTICLE
Norberto Carlos Chavez-Tapia, Beatriz A Sanchez-Jimenez, Desiree Vidaña-Perez, Beatriz Corrales-Rosas, Brenda Balderas-Garces, Diana Vera-Izaguirre, Fermin Jurado Santa Cruz, Cesar Maldonado-Garcia, Eva Juarez-Hernandez, Misael Uribe
Psoriasis has been related to metabolic dysfunction-associated fatty liver disease and, liver fibrosis. This study aimed to evaluate the prevalence of liver fibrosis in psoriasis and identify predictors for fibrosis. This is a cross-sectional study conducted from December 2012 to June 2016 assessing psoriasis and psoriatic arthritis patients attended at four centers in Mexico City. Data regarding history of the skin disease, previous and current medication, and previously diagnosed liver disease was collected...
2024: PloS One
https://read.qxmd.com/read/38623920/drosophila-melanogaster-as-a-model-organism-for-diabetes-ii-treatment-by-the-ethyl-acetate-fraction-of-atriplex-halimus-l
#31
JOURNAL ARTICLE
Omnia Montaser, Mona El-Aasr, Haytham O Tawfik, Wesam S Meshrif, Hanaa Elbrense
Type 2 diabetes (T2D) is the most common metabolic disorder. The undesirable effects of synthetic drugs demand a search for safe antidiabetic agents. This study aimed to assess the antidiabetic activity of different fractions of Atriplex halimus (petroleum ether 60-80, methylene chloride, ethyl acetate, and n-butanol) using Drosophila melanogaster larvae. Titers of total glucose and trehalose, as well as larval weight, were measured and compared with those of control and diabetic larvae. The expression of Drosophila insulin-like peptides (DILP2 and DILP3) and adipokinetic hormone (AKH) was evaluated...
April 16, 2024: Journal of Experimental Zoology. Part A, Ecological and Integrative Physiology
https://read.qxmd.com/read/38623789/moringa-isothiocyanate-1-mitigates-the-damage-of-oxidative-stress-and-apoptosis-in-diabetic-nephropathy-mice
#32
JOURNAL ARTICLE
Zhou Hua, Jiuhong Deng, Guiying Wang
OBJECTIVE: Diabetic nephropathy (DN) is a prevalent cause of end-stage kidney disease worldwide. Moringa isothiocyanate-1 (MIC-1) has shown potential for DN management, however, the exact mechanisms remain unclear. This research intended to evaluate the impact and mechanism of MIC-1 on DN. METHODS: Six C57BLKS/J-db/m mice served as controls. Eighteen C57BLKS/J-db/db mice were randomly separated into three groups: db/db, db/db + irbesartan (IBS), and db/db + MIC-1...
April 16, 2024: Histology and Histopathology
https://read.qxmd.com/read/38623675/microbiological-distribution-antimicrobial-susceptibility-and-risk-factors-of-polymicrobial-infections-in-diabetic-foot
#33
JOURNAL ARTICLE
Haojie Sun, Yamei Ma, Hao Heng, Xuekui Liu, Jun Liang, Houfa Geng
BACKGROUND: Diabetic foot infection (DFI) leads to poor prognosis and polymicrobial infections are usually the main cause. The study is to explore the microbiological distribution, antimicrobial drug susceptibility, and risk factors of polymicrobial infections in hospitalized patients with DFI. METHODS: This retrospective study included 160 patients with DFI in Wagner's grades 2, 3, and 4. Deep necrotic tissue was used to acquire specimens for microbiological culture...
April 1, 2024: Clinical Laboratory
https://read.qxmd.com/read/38623619/proteomic-analyses-in-diverse-populations-improved-risk-prediction-and-identified-new-drug-targets-for-type-2-diabetes
#34
JOURNAL ARTICLE
Pang Yao, Andri Iona, Alfred Pozarickij, Saredo Said, Neil Wright, Kuang Lin, Iona Millwood, Hannah Fry, Christiana Kartsonaki, Mohsen Mazidi, Yiping Chen, Fiona Bragg, Bowen Liu, Ling Yang, Junxi Liu, Daniel Avery, Dan Schmidt, Dianjianyi Sun, Pei Pei, Jun Lv, Canqing Yu, Michael Hill, Derrick Bennett, Robin Walters, Liming Li, Robert Clarke, Huaidong Du, Zhengming Chen
OBJECTIVE: Integrated analyses of plasma proteomics and genetic data in prospective studies can help assess the causal relevance of proteins, improve risk prediction, and discover novel protein drug targets for type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We measured plasma levels of 2,923 proteins using Olink Explore among ∼2,000 randomly selected participants from China Kadoorie Biobank (CKB) without prior diabetes at baseline. Cox regression assessed associations of individual protein with incident T2D (n = 92 cases)...
April 16, 2024: Diabetes Care
https://read.qxmd.com/read/38623388/characteristics-risk-factors-and-outcomes-in-acute-kidney-injury-patients-a-retrospective-cross-sectional-study-palestine
#35
JOURNAL ARTICLE
Abdallah Damin Abukhalil, Haya Alyazouri, Reem Alsheikh, Hadeel Kahla, Minna Mousa, Hosniyeh Ladadweh, Ni'meh Al-Shami, Yousef Sahoury, Hani Naseef, Abdullah Rabba
BACKGROUND: Acute kidney injury (AKI) is a major medical problem affecting patients' quality of life and healthcare costs. OBJECTIVES: This study evaluated the severity, risk factors, and outcomes of patients diagnosed with acute kidney injury (AKI), including community-acquired AKI (CA-AKI) and hospital-acquired AKI (HA-AKI), who were admitted to tertiary institutions in Palestine. METHODS: This retrospective cross-sectional study was conducted at multiple tertiary care hospitals in Palestine by reviewing patient charts from January 2020 to March 2023...
2024: TheScientificWorldJournal
https://read.qxmd.com/read/38622453/long-term-treatment-of-hereditary-transthyretin-amyloidosis-with-patisiran-multicentre-real-world-experience-in-italy
#36
JOURNAL ARTICLE
Luca Gentile, Anna Mazzeo, Chiara Briani, Silvia Casagrande, Marcella De Luca, Gian Maria Fabrizi, Christian Gagliardi, Chiara Gemelli, Francesca Forcina, Marina Grandis, Valeria Guglielmino, Giacomo Iabichella, Luca Leonardi, Alessandro Lozza, Fiore Manganelli, Roberta Mussinelli, Filomena My, Giuseppe Occhipinti, Silvia Fenu, Massimo Russo, Angela Romano, Alessandro Salvalaggio, Matteo Tagliapietra, Stefano Tozza, Giovanni Palladini, Laura Obici, Marco Luigetti
BACKGROUND: Hereditary transthyretin (ATTRv, v for variant) amyloidosis with polyneuropathy is a rare disease caused by mutations in the transthyretin gene. In ATTRv amyloidosis, multisystem extracellular deposits of amyloid cause tissue and organ dysfunction. Patisiran is a small interfering RNA molecule drug that reduces circulating levels of mutant and wild-type TTR proteins. Prior to its regulatory approval, patisiran was available in Italy through a compassionate use programme (CUP)...
April 16, 2024: Neurological Sciences
https://read.qxmd.com/read/38621986/-comparison-of-in-vivo-pharmacokinetics-of-twelve-constituents-in-qihe-fenqing-yin-in-normal-rats-and-diabetic-rats
#37
JOURNAL ARTICLE
Jiang-Yan Chen, Sheng Guo, Xiao-Xue Xu, Ya Yang, Yue Zhu, Hong-Jie Kang, Jin-Ao Duan
This paper aims to study the pharmacokinetic differences of twelve effective constituents(succinic acid, neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, protocatechuic aldehyde, caffeic acid, 5-O-ferulogeninic acid, p-coumaric acid, nuciferine, quercetin, oleanolic acid, and ursolic acid) in Qihe Fenqing Yin in normal and diabetic rats. The diabetic rat model was established by a high-fat diet combined with intraperitoneal injection of streptozocin. A UHPLC-QTRAP-MS/MS method was established for the simultaneous determination of 12 constituents in the plasma of normal rats and model rats after a single intragastric administration of Qihe Fenqing Yin...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621945/-mechanism-of-ultrafiltration-extract-of-angelicae-sinensis-radix-and-hedysari-radix-regulates-hif-1%C3%AE-signaling-pathway-mediated-by-renal-hypoxia-to-ameliorate-renal-fibrosis-in-dkd-rats
#38
JOURNAL ARTICLE
Xiao-Lin Zhang, Rong-Ke Li, Ting Gao, Qing-Quan Xu, Sheng-Fang Wan, Lei Zhang, Tian-Yi Lu
This study explored the mechanism of the ultrafiltration extract of Angelicae Sinensis Radix and Hedysari Radix in ameliorating renal fibrosis in the rat model of diabetic kidney disease(DKD) based on the expression of hypoxia-inducible factor-1α(HIF-1α)/vascular endothelial growth factor(VEGF) and HIF-1α/platelet-derived growth factor(PDGF)/platelet-derived growth factor receptor(PDGFR) signaling pathways in the DKD rats. After 1 week of adaptive feeding, 50 male SPF-grade Wistar rats were randomized into a blank group(n=7) and a modeling group...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621943/-effect-of-zuogui-jiangtang-qinggan-formula-on-lipid-metabolism-in-db-db-mouse-model-of-type-2-diabetes-mellitus-complicated-with-non-alcoholic-fatty-liver-disease
#39
JOURNAL ARTICLE
Min Zhou, Liu Li, Jun-Ju Zou, Xiu Liu, Yong-Jun Wu, Qin Xiang, Rong Yu
This study aims to explore the effect of Zuogui Jiangtang Qinggan Formula(ZGJTQGF) on the lipid metabolism in the db/db mouse model of type 2 diabetes mellitus(T2DM) complicated with non-alcoholic fatty liver disease(NAFLD) via the insulin receptor(INSR)/adenosine 5'-monophosphate(AMP)-activated protein kinase(AMPK)/sterol-regulatory element-binding protein 2(SREBP-2) signaling pathway. Twenty-four db/db mice were randomized into positive drug(metformin, 0.067 g·kg~(-1)) and low-(7.5 g·kg~(-1)) and high-dose(15 g·kg~(-1)) ZGJTQGF groups...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621942/-gualou-xiebai-banxia-decoction-treats-type-2-diabetes-mellitus-combined-with-acute-myocardial-infarction-via-chemerin-cmklr1-ppar%C3%AE-signaling-pathway
#40
JOURNAL ARTICLE
Lei Wang, Shuai Guan, Meng-Xue Wu, Hui Zhou, Qi-Tao Zhao, Li-Ying Xun
This study aims to investigate the effects of Gualou Xiebai Banxia Decoction(GXBD) on type 2 diabetes mellitus(T2DM) combined with acute myocardial infarction(AMI) in rats via chemerin/chemokine-like receptor 1(CMKLR1)/peroxisome proliferator-activated receptor α(PPARα) signaling pathway, and to explore the mechanism of GXBD in alleviating glucose and lipid metabolism disorders. The SD rats were randomized into control, model, positive control, and low-and high-dose GXBD groups. The rat model of T2DM was established by administration with high-fat emulsion(HFE) by gavage and intraperitoneal injection with streptozotocin, and then coronary artery ligation was performed to induce AMI...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
keyword
keyword
50876
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.